Ho Carole

Ho Carole is listed in filings as Chief Medical Officer at Denali Therapeutics Inc.. This profile follows SEC Form 4 activity through Aug 14, 2025, including sale activity. Recent filings connect the profile to Denali Therapeutics Inc. (DNLI), Royalty Pharma plc (RPRX), and Beam Therapeutics Inc. (BEAM). The current snapshot covers public activity from Aug 15, 2024 to Aug 14, 2025. Reported amounts are shown as $11.8K to $30.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.